Antares Pharma, Inc. (ATRS)

Stock-Based Compensation

$8.35M

TTM · Period ending: · USD

ATRS logo

ATRS Stock-Based Compensation

Latest reported$8.35M
ATRS TTM Stock-Based Comp ($0.00 → $8.35M)
High-resolution chart · PNG

ATRS stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
8,350,000
8,015,000
8,027,000
7,649,000
7,575,000
7,948,000
7,594,000
7,435,000
7,082,000
6,470,000
5,917,000
5,877,000
5,308,000
4,927,000
4,773,547
4,256,408
3,939,305
3,490,000
3,004,380
2,526,065
2,519,626
2,519,750
2,896,635
3,285,233
3,460,998
3,658,874
3,375,563
3,072,064
2,737,010
2,624,742
2,799,401
2,756,258
2,605,411
2,435,260
2,095,407
1,934,674
1,965,092
2,025,532
1,848,110
1,937,001
1,912,842
1,872,772
1,910,876
1,654,699
1,450,206
1,311,177
1,197,288
1,239,317
1,262,324
1,192,479
884,379
518,867
262,772
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.